Canada markets closed

Avadel Pharmaceuticals plc (AVDL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
18.82+0.52 (+2.84%)
At close: 04:00PM EDT
18.51 -0.31 (-1.65%)
After hours: 06:43PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-160,276
-160,276
-137,464
-77,329
7,028
Depreciation & amortization
1,766
1,766
1,493
815
1,690
Deferred income taxes
0
0
26,025
-15,666
-7,431
Stock based compensation
15,811
15,811
7,013
8,872
2,999
Change in working capital
-2,999
-2,999
24,535
3,695
-8,135
Accounts receivable
-12,103
-12,103
0
0
8,281
Inventory
-9,532
-9,532
0
0
-1,352
Accounts Payable
1,545
1,545
-3,108
4,232
-2,788
Other working capital
-128,511
-128,511
-71,020
-77,336
-48,832
Other non-cash items
4,058
4,058
8,094
2,303
875
Net cash provided by operating activites
-128,511
-128,511
-70,304
-77,310
-48,734
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-716
-26
-98
Purchases of investments
-237,229
-237,229
-3,414
-61,769
-131,407
Sales/Maturities of investments
187,136
187,136
83,828
102,224
36,284
Net cash used for investing activites
-50,093
-50,093
79,698
56,929
-69,721
Cash flows from financing activities
Debt repayment
-21,165
-21,165
0
0
-
Common stock issued
146,064
146,064
25,318
0
179,683
Common stock repurchased
-
-
-
-
0
Other financing activites
8,143
8,143
-13,457
-
-
Net cash used privided by (used for) financing activities
135,335
135,335
14,543
263
179,683
Net change in cash
-42,814
-42,814
23,273
-21,014
61,948
Cash at beginning of period
73,981
73,981
50,708
71,722
9,774
Cash at end of period
31,167
31,167
73,981
50,708
71,722
Free Cash Flow
Operating Cash Flow
-128,511
-128,511
-70,304
-77,310
-48,734
Capital Expenditure
-
-
-716
-26
-98
Free Cash Flow
-128,511
-128,511
-71,020
-77,336
-48,832